These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9658790)

  • 1. [Muscular enzyme level disorders and a malignant hyperthermia susceptability test: postoperative study of a patient with elevated CPK].
    Perugini M; Montironi C; Rocchi S
    Minerva Anestesiol; 1998; 64(1-2):45-50. PubMed ID: 9658790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genetics of malignant hyperthermia: evidence for heterogeneity.
    McPherson E; Taylor CA
    Am J Med Genet; 1982 Mar; 11(3):273-85. PubMed ID: 7081293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyopathy in malignant hyperthermia.
    Rivera VM; Patten BM
    J Clin Psychiatry; 1978 Jan; 39(1):67-71. PubMed ID: 580262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core myopathies and risk of malignant hyperthermia.
    Klingler W; Rueffert H; Lehmann-Horn F; Girard T; Hopkins PM
    Anesth Analg; 2009 Oct; 109(4):1167-73. PubMed ID: 19762745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative malignant hyperthermia: an analysis of cases from the North American Malignant Hyperthermia Registry.
    Litman RS; Flood CD; Kaplan RF; Kim YL; Tobin JR
    Anesthesiology; 2008 Nov; 109(5):825-9. PubMed ID: 18946294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum creatine kinase level as a screening test for susceptibility to malignant hyperthermia.
    Paasuke RT; Brownell AK
    JAMA; 1986 Feb; 255(6):769-71. PubMed ID: 3944979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant hyperthermia in a 3-month-old infant: a case report.
    Pennington GP; Joeris L
    J Med Assoc Ga; 1996 Sep; 85(3):162-3. PubMed ID: 8870451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant hyperpyrexia.
    Denborough MA
    Compr Ther; 1975 Dec; 1(8):51-6. PubMed ID: 770064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fulminant MH crisis during the ninth general anaesthesia].
    Adam H; Gottschaldt U; Pausch NC; Rüffert H; Sipli KM
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Oct; 42(10):692-9. PubMed ID: 17968765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exceptionally elevated creatine kinase levels in a laryngectomized patient: hypothyroid myopathy.
    Cinamon U
    J Laryngol Otol; 2004 Aug; 118(8):651-2. PubMed ID: 15453946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthermic reaction to haloperidol with rigidity, associated to central core disease.
    Calore EE; Cavaliere MJ; Perez NM; Russo DH; Wakamatsu A; Razzouk D
    Acta Neurol (Napoli); 1994 Aug; 16(4):157-61. PubMed ID: 7856468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine phosphokinase in long-term dialysis patients.
    Soffer O; Fellner SK; Rush RL
    Arch Intern Med; 1981 Feb; 141(2):181-8. PubMed ID: 7458513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The King syndrome: malignant hyperthermia, myopathy, and multiple anomalies.
    McPherson EW; Taylor CA
    Am J Med Genet; 1981; 8(2):159-65. PubMed ID: 7282770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of pre-operative creatin phosphokinase (CPK) level--usefulness as a screening test for malignant hyperpyrexia (author's transl)].
    Morikawa S; Murata M; Murata H; Iwai S
    Masui; 1979 Feb; 28(2):187-96. PubMed ID: 423358
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
    Burkman JM; Posner KL; Domino KB
    Anesthesiology; 2007 May; 106(5):901-6; quiz 1077-8. PubMed ID: 17457120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extra-cardial rise of the CPK in the screening of urgent diagnostic (among others, a case of anaesthesia induced myoglobinuria and a case of malignant hypertermia) (author's transl)].
    Bernhardt D; Hörder MH
    Med Klin; 1977 Nov; 72(46):1967-71. PubMed ID: 927298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and morphological findings in a case of malignant hyperthermia (author's transl)].
    Faber P; Gullotta F; Koenen FW
    Dtsch Med Wochenschr; 1975 Sep; 100(39):1974-6. PubMed ID: 1157706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia and central core disease causative mutations in Swedish patients.
    Broman M; Islander G; Müller CR; Ranklev-Twetman E
    Acta Anaesthesiol Scand; 2007 Jan; 51(1):50-3. PubMed ID: 17081152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anesthetic management of the King-Denborough syndrome].
    Iwatsubo T; Yoshikawa M; Karashima Y; Kurita N; Shimoda T; Takahashi H; Horiuchi T; Kitaguchi K; Furuya H
    Masui; 2001 Apr; 50(4):390-3. PubMed ID: 11345752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.